Dzieciatkowska Monika, D'Alessandro Angelo, Burke Timothy A, Kelher Marguerite R, Moore Ernest E, Banerjee Anirban, Silliman Christopher C, West Bernadette F, Hansen Kirk C
Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States.
Bonfils Blood Center, Denver, CO, United States.
J Proteomics. 2015 Jan 1;112:190-209. doi: 10.1016/j.jprot.2014.08.016. Epub 2014 Sep 6.
Proteomics has identified potential pathways involved in platelet storage lesions, which correlate with untoward effects in the recipient, including febrile non-haemolytic reactions. We hypothesize that an additional pathway involves protein mediators that accumulate in the platelet supernatants during routine storage in a donor gender-specific fashion. Apheresis platelet concentrates were collected from 5 healthy males and 5 females and routinely stored. The 14 most abundant plasma proteins were removed and the supernatant proteins from days 1 and 5 were analyzed via 1D-SDS-PAGE/nanoLC-MS/MS, before label-free quantitative proteomics analyses. Findings from a subset of 18 proteins were validated via LC-SRM analyses against stable isotope labeled standards. A total of 503 distinct proteins were detected in the platelet supernatants from the 4 sample groups: female or male donor platelets, either at storage day 1 or 5. Proteomics suggested a storage and gender-dependent impairment of blood coagulation mediators, pro-inflammatory complement components and cytokines, energy and redox metabolic enzymes. The supernatants from female donors demonstrated increased deregulation of structural proteins, extracellular matrix proteins and focal adhesion proteins, possibly indicating storage-dependent platelet activation. Routine storage of platelet concentrates induces changes in the supernatant proteome, which may have effects on the transfused patient, some of which are related to donor gender.
The rationale behind this study is that protein components in platelet releasates have been increasingly observed to play a key role in adverse events and impaired homeostasis in transfused recipients. In this view, proteomics has recently emerged as a functional tool to address the issue of protein composition of platelet releasates from buffy coat-derived platelet concentrates in the blood bank. Despite early encouraging studies on buffy coat-derived platelet concentrates, platelet releasates from apheresis platelets have not been hitherto addressed by means of extensive proteomics technologies. Indeed, apheresis platelets are resuspended in donors' plasma, which hampers detection of less abundant proteins, owing to the overwhelming abundance of albumin (and a handful of other proteins), and the dynamic range of protein concentrations of plasma proteins. In order to cope with these issues, we hereby performed an immuno-affinity column-based depletion of the 14 most abundant plasma proteins. Samples were thus assayed via GeLC-MS, a workflow that allowed us to cover an unprecedented portion of the platelet supernatant proteome, in comparison to previous transfusion medicine-oriented studies in the literature. Finally, we hereby address the issue of biological variability, by considering the donor gender as a key factor influencing the composition of apheresis platelet supernatants. As a result, we could conclude that platelet supernatants from male and female donors are not only different in the first place, but they also store differently. This conclusion has been so far only suggested by classic transfusion medicine studies, but has been hitherto unsupported by actual biochemistry/proteomics investigations. In our opinion, the main strengths of this study are related to the analytical workflow (immunodepletion and GeLC-MS) and proteome coverage, the translational validity of the results (from a transfusion medicine standpoint) and the biological conclusion about the intrinsic (and storage-dependent) gender-related differences of platelet supernatants.
蛋白质组学已确定了参与血小板储存损伤的潜在途径,这些途径与受血者的不良影响相关,包括发热性非溶血性反应。我们假设另一条途径涉及在常规储存期间以供体性别特异性方式在血小板上清液中积累的蛋白质介质。从5名健康男性和5名女性中采集单采血小板浓缩物并进行常规储存。去除14种最丰富的血浆蛋白,在进行无标记定量蛋白质组学分析之前,通过一维SDS - PAGE/纳升液相色谱 - 串联质谱法分析第1天和第5天的上清液蛋白。通过液相色谱 - 选择反应监测(LC - SRM)分析针对稳定同位素标记标准对18种蛋白质的子集进行验证。在4个样本组(女性或男性供体的血小板,分别在储存第1天或第5天)的血小板上清液中总共检测到503种不同的蛋白质。蛋白质组学表明,血液凝固介质、促炎补体成分和细胞因子、能量和氧化还原代谢酶存在储存和性别依赖性损伤。女性供体的上清液显示结构蛋白、细胞外基质蛋白和粘着斑蛋白的失调增加,这可能表明储存依赖性血小板活化。血小板浓缩物的常规储存会引起上清液蛋白质组的变化,这可能会对受血患者产生影响,其中一些与供体性别有关。
本研究背后的基本原理是,越来越多地观察到血小板释放物中的蛋白质成分在受血者的不良事件和内环境稳态受损中起关键作用。从这个角度来看,蛋白质组学最近已成为一种功能工具,用于解决血库中来源于 Buffy 层的血小板浓缩物的血小板释放物的蛋白质组成问题。尽管早期对来源于 Buffy 层的血小板浓缩物的研究令人鼓舞,但单采血小板的血小板释放物迄今为止尚未通过广泛的蛋白质组学技术进行研究。实际上,单采血小板悬浮在供体血浆中,由于白蛋白(和少数其他蛋白质)的大量存在以及血浆蛋白浓度的动态范围,这阻碍了对含量较少蛋白质的检测。为了解决这些问题,我们在此通过基于免疫亲和柱的方法去除14种最丰富的血浆蛋白。因此,通过凝胶内消化液相色谱 - 质谱法(GeLC - MS)对样品进行分析,与文献中以前的输血医学相关研究相比,该工作流程使我们能够覆盖血小板上清液蛋白质组中前所未有的部分。最后,我们通过将供体性别视为影响单采血小板上清液组成的关键因素来解决生物学变异性问题。结果,我们可以得出结论,男性和女性供体的血小板上清液不仅一开始就不同,而且它们的储存方式也不同。到目前为止,这一结论仅由经典输血医学研究提出,但迄今为止尚未得到实际生物化学/蛋白质组学研究的支持。我们认为,本研究的主要优势与分析工作流程(免疫去除和 GeLC - MS)和蛋白质组覆盖范围、结果的转化有效性(从输血医学角度)以及关于血小板上清液内在(和储存依赖性)性别相关差异的生物学结论有关。